Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-05-30
2006-05-30
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S263210, C514S263220, C514S263350, C514S263360, C544S267000, C544S269000, C544S271000
Reexamination Certificate
active
07053096
ABSTRACT:
Disclosed are compounds having selective hydrolytic potential. The disclosed compounds are useful as compounds having selective stability and are capable of undergoing programmed hydrolysis in biologic systems.
REFERENCES:
patent: 286041 (1988-10-01), None
patent: 17684 (1993-09-01), None
Allevi et al., Tetrahdron Letters, vol. 33, No. 33, pp. 4831-4834, “A Short and Simple Synthesis of the Antitumor Agent Etoposide”, 1992.
Bundgaard, et al., J. Med. Chem., vol. 32, No. 12, pp. 2503-2507, “A Novel Solution-Stable, Water-Soluble Prodrug Type for Drugs Containing a Hydroxyl or an NH-Acidic Group”, 1989.
Hussain et al., J. Pharma, Sci., vol. 76, No. 5, pp. 356-358, “Improvement of the Oral Bioavailability of Naltrexone in Dogs: A Prodrug Approach”, 1987.
Riley et al., J. Chem. Education, vol. 65, No. 11, pp. 947-953, “The Prodrug Concept and New Drug Design and Development”, 1988.
Bredl Charles R.
Klein J. Peter
Kumar Anil M.
Porubek David
Berch Mark L.
Cell Therapeutics Inc.
Foley & Lardner LLP
LandOfFree
Compounds having selective hydrolytic potentials does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds having selective hydrolytic potentials, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds having selective hydrolytic potentials will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3649362